Natera’s Signatera Genome Highlighted at ESMO Symposium
Natera said its oncology portfolio appeared in 25 ESMO abstracts, including nine oral presentations.
Natera said its oncology portfolio appeared in 25 ESMO abstracts, including nine oral presentations.